Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibodies, Neoplasm”

3,354 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,354 results

Testing effectiveness (Phase 2)Looking for participantsNCT06479239
What this trial is testing

Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer

Who this might be right for
Pancreas CancerPancreatic Cancer
University of Virginia 23
Testing effectiveness (Phase 2)Study completedNCT03430479
What this trial is testing

Anti PD-1 Antibody With Radiation Therapy in Patients With HER2-negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Kyoto Breast Cancer Research Network 32
Testing effectiveness (Phase 2)Looking for participantsNCT06792162
What this trial is testing

PD-1 Antibody Carilizumab Combined with Apatinib for Unresectable Stage III and IV DMMR Gastric Cancer

Who this might be right for
Gastric Cancer
Peking University Third Hospital 20
Early research (Phase 1)Looking for participantsNCT06041516
What this trial is testing

Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors and Carcinomas

Who this might be right for
Neuroendocrine CarcinomasNeuroendocrine TumorsCarcinoma, Neuroendocrine+2 more
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)UnknownNCT03857815
What this trial is testing

Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 30
Early research (Phase 1)UnknownNCT03852823
What this trial is testing

Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours

Who this might be right for
Advanced Solid TumoursCervical CancerMalignant Mesothelioma+2 more
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 192
Early research (Phase 1)Study completedNCT04990037
What this trial is testing

The Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Cantargia AB 25
Testing effectiveness (Phase 2)UnknownNCT04398524
What this trial is testing

A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC

Who this might be right for
Squamous Cell Carcinoma of the Oropharynx
ISA Pharmaceuticals 65
Testing effectiveness (Phase 2)UnknownNCT06406673
What this trial is testing

A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung Cancer

Who this might be right for
Extensive Small Cell Lung Cancer
Henan Cancer Hospital 70
Testing effectiveness (Phase 2)Study completedNCT00600054
What this trial is testing

Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma

Who this might be right for
Recurrent Diffuse Pontine Gliomas
YM BioSciences 44
Early research (Phase 1)Study completedNCT01503242
What this trial is testing

90 Y-BC8-DOTA Monoclonal Antibody, Fludarabine Phosphate, and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Fred Hutchinson Cancer Center 15
Testing effectiveness (Phase 2)Ended earlyNCT00642941
What this trial is testing

R1507 in Participants With Recurrent or Refractory Sarcoma

Who this might be right for
Sarcoma
Hoffmann-La Roche 317
Testing effectiveness (Phase 2)Looking for participantsNCT04219254
What this trial is testing

BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
BioInvent International AB 197
Early research (Phase 1)Ended earlyNCT02221505
What this trial is testing

Phase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid Leukemia

Who this might be right for
cKIT-positive Solid TumorsAML
Novartis Pharmaceuticals 3
Early research (Phase 1)Study completedNCT00674947
What this trial is testing

A Phase I Study of BIIB015 in Relapsed/Refractory Solid Tumors

Who this might be right for
Solid Tumors
Biogen 55
Testing effectiveness (Phase 2)Study completedNCT03035331
What this trial is testing

Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma

Who this might be right for
Aggressive Non-Hodgkin LymphomaIndolent Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell Lymphoma+7 more
Mayo Clinic 11
Large-scale testing (Phase 3)Active Not RecruitingNCT04102098
What this trial is testing

Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 668
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06416930
What this trial is testing

Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 59
Large-scale testing (Phase 3)Ended earlyNCT02450331
What this trial is testing

Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection

Who this might be right for
Carcinoma, Transitional Cell
Hoffmann-La Roche 809
Not applicableLooking for participantsNCT06574698
What this trial is testing

Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma

Who this might be right for
NeuroblastomaGD2 Antibody (Naxitamab)
Guangzhou Women and Children's Medical Center 64
Load More Results